Additional information
by John R. White (Editor), Joshua J. Nuemiller (Editor)
The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association's Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
- Neuropathy
- Chronic Kidney Disease
- Retinopathy
- Hypoglycemia
- Obesity
- Depression
Author Biography
JOSHUA J. NUEMILLER, PHARMD, CDCES, FADCES, FASCP, is Vice Chair and Allen I. White Distinguished Professor, Pharmacotherapy, at the College of Pharmacy and Pharmaceutical Sciences at Washington State University. Dr. Neumiller currently serves as the ADA's president-elect for healthcare & education and is the author of Practical Insulin.
